BHVN ▲ +1.5% - Biohaven Ltd. $BHVN Licensing Agreement with Ono Pharma for Extracellular IgG Degraders in Japan and Select Asian Regions. Biohaven to receive $80M upfront 08-OCT-2026 05:59 AM ET